Meprobamate
4 NDCs across 2 manufacturers|4 Generic,0 Brand
Meprobamate is used to treat anxiety disorders, headache, muscle rigidity, muscle spasticity and spasm, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $1 million on Meprobamate across 3,285 claims for 656 beneficiaries.
Meprobamate is available as 4 NDCs from 2 manufacturers (4 generic, 0 brand), with NADAC prices from $4.54 to $5.89 per EA — a 30% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
4G / 0B
Manufacturers
2
competing in market
Price Spread
$4.54 – $5.89
per EA
7d Activity
avg -0.6% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Alembic Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing MEPROBAMATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MEPROBAMATE 400 MG TABLET | $5.8924 per EA | -1.68% |
MEPROBAMATE 400 MG TABLET | $5.8924 per EA | -1.68% |
MEPROBAMATE 200 MG TABLET | $4.5426 per EA | +0.55% |
MEPROBAMATE 200 MG TABLET | $4.5426 per EA | +0.55% |
Frequently Asked Questions
What is Meprobamate used to treat?
Meprobamate is used to treat anxiety disorders, headache, muscle rigidity, muscle spasticity and spasm, per the National Library of Medicine's MED-RT classification.
When did Meprobamate become available as a generic?
FDA approved the first generic Meprobamate (ANDA) on Jan 1, 1982.
How much does Medicare spend on Meprobamate?
In 2024, Medicare Part D spent $1 million on Meprobamate across 3,285 claims for 656 beneficiaries.
How many Meprobamate products are on the market?
The Meprobamate drug market contains 4 NDCs from 2 manufacturers — 4 generic and 0 brand products.
What is the price range for Meprobamate?
NADAC reference prices for Meprobamate range from $4.5426 to $5.8924 per EA — a 30% difference between cheapest and most expensive.
Which manufacturers make Meprobamate?
2 manufacturers list Meprobamate in NADAC. Ranked by number of NDCs, the largest are Alembic Pharmaceuticals Inc. (2), Cipla USA Inc. (2).
How has the price of Meprobamate changed recently?
Over the past 7 days, 2 Meprobamate NDCs rose and 2 fell, with a market-wide average change of -0.6%.